Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Breast Cancer Research and Treatment
|
May 12, 2017
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
Gail D Lewis Phillips, Merry C Nishimura, Jennifer Arca Lacap, et al.
Journal of Medicinal Chemistry
|
September 10, 2009
A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2
Herman S Gill, Jeff N Tinianow, Annie Ogasawara, et al.
Theranostics
|
March 5, 2016
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice
Jeff N Tinianow, Darpan N Pandya, Sylvie L Pailloux, et al.
Neoplasia (New York, N.Y.)
|
September 15, 2019
VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models
Johannes Riegler, Herman Gill, Annie Ogasawara, et al.
Nuclear Medicine and Biology
|
March 30, 2010
Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
Jeff N Tinianow, Herman S Gill, Annie Ogasawara, et al.
Nuclear Medicine and Biology
|
May 17, 2017
Preparation and evaluation of L- and D-5-[<sup>18</sup>F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases
Tang Tang, Herman S Gill, Annie Ogasawara, et al.
Nuclear Medicine and Biology
|
September 12, 2023
GTP1 metabolic stability assessment: A study of the tau PET tracer [<sup>18</sup>F]GTP1
Jan Marik, Sharyl Rich, Gauri Deshmukh, et al.
The AAPS Journal
|
January 5, 2020
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific <sup>89</sup>Zr-Labeled Immuno-PET Clinical Imaging Agent
Herman Gill, Richard Seipert, Vincent M Carroll, et al.
Molecular Cancer Therapeutics
|
October 21, 2016
Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET
Anton G T Terwisscha van Scheltinga, Annie Ogasawara, Glenn Pacheco, et al.
Journal of Medicinal Chemistry
|
July 5, 2022
Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation
Richard Zang, Aline Barth, Harvey Wong, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Breast Cancer Research and Treatment
|
May 12, 2017
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
Gail D Lewis Phillips, Merry C Nishimura, Jennifer Arca Lacap, et al.
Journal of Medicinal Chemistry
|
September 10, 2009
A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2
Herman S Gill, Jeff N Tinianow, Annie Ogasawara, et al.
Theranostics
|
March 5, 2016
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice
Jeff N Tinianow, Darpan N Pandya, Sylvie L Pailloux, et al.
Neoplasia (New York, N.Y.)
|
September 15, 2019
VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models
Johannes Riegler, Herman Gill, Annie Ogasawara, et al.
Nuclear Medicine and Biology
|
March 30, 2010
Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
Jeff N Tinianow, Herman S Gill, Annie Ogasawara, et al.
Nuclear Medicine and Biology
|
May 17, 2017
Preparation and evaluation of L- and D-5-[<sup>18</sup>F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases
Tang Tang, Herman S Gill, Annie Ogasawara, et al.
Nuclear Medicine and Biology
|
September 12, 2023
GTP1 metabolic stability assessment: A study of the tau PET tracer [<sup>18</sup>F]GTP1
Jan Marik, Sharyl Rich, Gauri Deshmukh, et al.
The AAPS Journal
|
January 5, 2020
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific <sup>89</sup>Zr-Labeled Immuno-PET Clinical Imaging Agent
Herman Gill, Richard Seipert, Vincent M Carroll, et al.
Molecular Cancer Therapeutics
|
October 21, 2016
Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET
Anton G T Terwisscha van Scheltinga, Annie Ogasawara, Glenn Pacheco, et al.
Journal of Medicinal Chemistry
|
July 5, 2022
Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation
Richard Zang, Aline Barth, Harvey Wong, et al.
Page
of 6